Status:
COMPLETED
Epidemiological Study to Evaluate Adherence to Treatment in Bipolar Disorder: Adherence Study
Lead Sponsor:
AstraZeneca
Conditions:
Bipolar Disorder
Eligibility:
All Genders
18+ years
Brief Summary
The purpose of this study is to estimate adherence to treatment in bipolar patients, to characterize patients based on adherence degree and to describe the variables linked to poor adherence to treatm...
Eligibility Criteria
Inclusion
- Patients diagnosed with bipolar disorder I or II DSM-IV
- Patients treated with at least one oral antipsychotic
- Subjects able to read and write
Exclusion
- Patients participating in clinical trials
Key Trial Info
Start Date :
July 1 2009
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
October 1 2009
Estimated Enrollment :
300 Patients enrolled
Trial Details
Trial ID
NCT00927420
Start Date
July 1 2009
End Date
October 1 2009
Last Update
October 30 2009
Active Locations (24)
Enter a location and click search to find clinical trials sorted by distance.
1
Research Site
Las Palmas, Gran Canarias, Spain
2
Research Site
Calahorra, La Rioja, Spain
3
Research Site
Langreo, Principality of Asturias, Spain
4
Research Site
San Cristóbal de La Laguna, Tenerife, Spain